Keenan, T. D., Vitale, S., Agrón, E., Domalpally, A., Antoszyk, A. N., Elman, M. J., . . . Chew, E. Y. (2019). Visual acuity outcomes after anti-VEGF treatment for neovascular age-related macular degeneration: AREDS2 Report Number 19. Ophthalmol Retina.
Citação norma ChicagoKeenan, Tiarnan D., Susan Vitale, Elvira Agrón, Amitha Domalpally, Andrew N. Antoszyk, Michael J. Elman, Traci E. Clemons, and Emily Y. Chew. "Visual Acuity Outcomes After Anti-VEGF Treatment for Neovascular Age-related Macular Degeneration: AREDS2 Report Number 19." Ophthalmol Retina 2019.
Citação norma MLAKeenan, Tiarnan D., et al. "Visual Acuity Outcomes After Anti-VEGF Treatment for Neovascular Age-related Macular Degeneration: AREDS2 Report Number 19." Ophthalmol Retina 2019.